Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03134313
Recruitment Status : Completed
First Posted : April 28, 2017
Results First Posted : July 2, 2017
Last Update Posted : July 2, 2017
Sponsor:
Information provided by (Responsible Party):
Masimo Corporation

Study Type Interventional
Study Design Intervention Model: Single Group Assignment;   Masking: None (Open Label);   Primary Purpose: Other
Condition Healthy
Intervention Device: Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor
Enrollment 25
Recruitment Details  
Pre-assignment Details  
Arm/Group Title R1-25 Sensor
Hide Arm/Group Description

All subjects will be enrolled in the test group and will receive Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor

Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor

Period Title: Overall Study
Started 25
Completed 25
Not Completed 0
Arm/Group Title R1-25 Sensor
Hide Arm/Group Description

All subjects will be enrolled in the test group and will receive Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor

Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor

Overall Number of Baseline Participants 25
Hide Baseline Analysis Population Description
[Not Specified]
Age, Categorical  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 25 participants
<=18 years
0
   0.0%
Between 18 and 65 years
25
 100.0%
>=65 years
0
   0.0%
Sex: Female, Male  
Measure Type: Count of Participants
Unit of measure:  Participants
Number Analyzed 25 participants
Female
7
  28.0%
Male
18
  72.0%
Region of Enrollment  
Measure Type: Number
Unit of measure:  Participants
United States Number Analyzed 25 participants
25
1.Primary Outcome
Title Accuracy of SpHb on R1-25 by Arms Calculation
Hide Description Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from the pulse oximeter hemoglobin value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms Error value.
Time Frame 1-5 hours per subject
Hide Outcome Measure Data
Hide Analysis Population Description
[Not Specified]
Arm/Group Title R1-25 Sensor
Hide Arm/Group Description:
All subjects will be enrolled in the test group and will receive Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor
Overall Number of Participants Analyzed 25
Measure Type: Number
Unit of Measure: g/dL
1.0
Time Frame [Not Specified]
Adverse Event Reporting Description [Not Specified]
 
Arm/Group Title R1-25 Sensor
Hide Arm/Group Description All subjects will be enrolled in the test group and will receive Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor
All-Cause Mortality
R1-25 Sensor
Affected / at Risk (%)
Total   0/25 (0.00%) 
Show Serious Adverse Events Hide Serious Adverse Events
R1-25 Sensor
Affected / at Risk (%)
Total   0/25 (0.00%) 
Show Other (Not Including Serious) Adverse Events Hide Other (Not Including Serious) Adverse Events
Frequency Threshold for Reporting Other Adverse Events 0%
R1-25 Sensor
Affected / at Risk (%)
Total   0/25 (0.00%) 
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Layout table for Results Point of Contact information
Name/Title: Vikram Ramakanth
Organization: Masimo
EMail: clinicalresearchdept@masimo.com
Layout table for additonal information
Responsible Party: Masimo Corporation
ClinicalTrials.gov Identifier: NCT03134313     History of Changes
Other Study ID Numbers: TR18670-1029
First Submitted: April 14, 2017
First Posted: April 28, 2017
Results First Submitted: May 8, 2017
Results First Posted: July 2, 2017
Last Update Posted: July 2, 2017